FitLife Brands, Inc. (FTLF) research, news, and more from GeoInvesting

Company description

Thu, 14 Feb 2013 05:00:00 GMT

FitLife Brands is a manufacturer of innovative and proprietary nutritional supplements for health conscious consumers. FitLife markets over 50 different dietary supplements to promote sports nutrition, improved performance, weight loss and general health primarily through domestic and international GNC® franchise locations. The company, which recently changed its name from Bond Labs, Inc. to FitLife Brands, Inc., is headquartered in Omaha, Nebraska.

Research

Thu, 13 Nov 2025 05:00:00 GMT

FitLife Brands, Inc. (NASDAQ:FTLF) ($18.97; $178.1M market cap) announced Q3 2025 results:

Q3 sales of $23.5 million vs. $16.0 million in the prior year, slightly below analyst estimates of $23.8 million
Q3 2025 GAAP EPS: $0.09 vs. $0.21 in the prior year
Q3 2025 Non-GAAP EPS of $0.21 vs $0.21 in the prior year, below analyst estimates of $0.27
Completed acquisition of Irwin Naturals on August 8, 2025
Irwin contributed $6.8 million to Q3 revenue
Gross margin was 37.2% (38.9% excluding Irwin inventory step-up), down from 43.8%

Management Commentary:

"Although we are still working through the previously disclosed challenges associated with our MRC business, we are very encouraged by the performance of our other brands during the third quarter of 2025, with MusclePharm organic revenue increasing 55% and Legacy FitLife organic revenue excluding MRC increasing 8%."

“We are pleased with the strong revenue performance of the MusclePharm brand, with wholesale revenue increasing 112% on a year-over-year basis during the quarter. This growth is a function of higher sales to existing customers as well as gaining new distribution.”

“Irwin is also off to a good start. As is the case with all acquisitions, there are a number of challenges that we are working through, but these challenges also represent opportunities for improved performance and we remain excited about the Irwin brands and their potential.”

“Our first sale of Irwin products on Amazon occurred on October 11, 2025. Since then, our sales on Amazon have increased consistently and are currently around $10,000 per day, or approximately $3.6 million on an annualized basis.”

“In addition, we continue to work toward capturing supply chain and SG&A efficiencies at Irwin.”

“At MRC, we continue to work on initiatives designed to generate revenue off-Amazon as well as drive additional traffic to our listings on Amazon.”

“Our primary concerns right now relate to the increasing cost of whey protein, which primarily affects our MusclePharm brand, and general consumer weakness. Although we remain optimistic about our brands and their long-term potential, these factors have an uncertain near-term effect.”

FitLife Brands, Inc. develops and markets nutritional supplements, wellness products, and natural skincare across various health-focused categories through retail, e-commerce, and franchised channels.

Research

Thu, 14 Aug 2025 17:23:17 GMT

FitLife Brands (NASDAQ: FTLF) ($16.22; $152.3M market cap) announced Q2 2025 results:

Q2 2025 sales of $16.1 million vs. $16.9 million in the prior year, in line with analyst estimates of $16.1 million
Q2 2025 adjusted EPS: $0.24 vs. $0.27 in the prior year, ahead of analyst estimates of $0.18
Adjusted EBITDA: $3.3 million, down 13% YoY
Gross margin declined to 42.8% from 44.8%
Completed acquisition of Irwin Naturals on August 8, 2025, for $42.5 million
Net income declined to $1.7 million from $2.6 million, with M&A-related expenses cited as the main reason
Ended Q2 with $10.9 million in term loans, $6.6 million in cash, and net debt of $4.3 million

"As previously disclosed, the second quarter of 2025 was strong for our Legacy FitLife business, but somewhat challenged for MRC. With regard to Legacy FitLife, we benefitted from a slight increase in wholesale revenue and strong growth in online revenue.

Among our existing brands, the performance of the Dr. Tobias brand is our primary concern, primarily due to reduced session counts on Amazon. However, once customers get to the brand’s product pages, they are converting at the same or higher percentages. We are focused on a number of initiatives to increase session counts, including targeted increases in advertising spend, optimizing SEO for our listings, and driving external traffic to our Amazon product pages.

With regard to MusclePharm, the efforts of our sales team continue to bear fruit. We continue to gain new distribution for a number of products, including the RTDs. Wholesale revenue for this brand is somewhat lumpy, so quarter-to-quarter wholesale revenue may not accurately reflect our progress. Monthly wholesale revenue for MusclePharm in July was the highest it has ever been since we bought the brand.

Last, we are very excited about Irwin Naturals... Irwin generated revenue of approximately $60 million at a gross margin of approximately 35%. We expect to generate improved gross margins over time... Irwin’s SG&A for the trailing twelve months... was approximately $14.5 million. As previously announced, we expect annual SG&A to be approximately $1.5 million lower... We expect to identify further cost-savings opportunities... We are equally excited about the Irwin team and are delighted to welcome them to the FitLife family. We look forward to updating our investors on Irwin’s progress during our third quarter earnings call.”

Our Quick Take:

Despite the weak Q2, we remain interested in FTLFs management again demonstrating its ability to expand through accretive, non-dilutive M&A, this time with the $42.5M purchase of Irwin Naturals. Still, we need to be mildly concerned over the ability of FTLF to post consistent organic growth, not solely relying on acquisitions.

Regardless, given the current weakness in parts of FTLF business, this deal arrived at the right time. Will management stabilize MRC’s Dr. Tobias brand traffic, keep MusclePharm’s recent distribution wins on track, and quickly capture Irwin’s margin upside?

FitLife Brands, Inc. develops and markets nutritional supplements, wellness products, and natural skincare across various health-focused categories through retail, e-commerce, and franchised channels

Research

Tue, 05 Aug 2025 19:38:37 GMT

FitLife Brands, Inc. (NASDAQ:FTLF) ($13.05; $122.6M market cap) announced the acquisition of substantially all assets of Irwin Naturals under Section 363 of the US Bankruptcy Code:

Key highlights:

FitLife will acquire Irwin Naturals and related affiliates in an all-cash transaction valued at $42.5 million.
No shares will be issued; the deal is expected to be accretive to shareholders.
The combined company is expected to generate over $120 million in annual revenue and $20–25 million in adjusted EBITDA.
The purchase includes $16 million of net working capital; acquisition multiple is under 6x EBITDA (pre-synergy).
Funding sources include cash on hand, a new $40.625 million term loan, and an upsized $10 million revolver from First Citizens Bank.
Expected post-close leverage is under 2.25x EBITDA.
Irwin’s revenue mix: 61% mass market (CVS, Walmart, Walgreens, Costco Canada), 35% health food, 4% direct-to-consumer.
FitLife plans to internalize Irwin’s online revenue and expand margin through e-commerce, including Amazon.
SG&A cost savings of $1.5 million expected post-acquisition; 50 Irwin employees retained.
Q2 2025 preview: revenue expected to decline 4–5% YoY to $16.0–$16.2 million, driven by a single MRC product underperformance.
Q2 net income guidance: $1.6–$1.8 million; adjusted EBITDA: $3.2–$3.4 million.

"We are thrilled to welcome the Irwin brands and team members to the FitLife family. Irwin Naturals is a brand we have known and admired for a long time. We believe that our complementary sales channels and product portfolios will benefit both businesses, and we are excited for what the future holds." – Dayton Judd, CEO

Our Quick Take:

Given that FTLF growth rate had been slowing of late, we have been waiting for the company to consummate an acquisition to re-accelerate growth. Interestingly, just like it did when it acquired MusclePharm, this acquisition was also through bankruptcy proceedings.

FitLife’s acquisition of Irwin Naturals reflects the company’s continued focus on executing disciplined, accretive transactions without issuing equity. Consistent with prior deals, management plans to drive margin improvement by internalizing e-commerce operations and streamlining SG&A. The integration approach aligns with how FitLife managed previous acquisitions, including MRC and MusclePharm, where operational improvements and profitability gains followed post-close (although still not to the degree and consistency we would like to see).

That said, this could be the company’s most complex acquisition to date, with a large retail footprint and broader operational scope. While FitLife has a history of integrating brands efficiently, the size and channel mix of Irwin introduces new challenges. Management’s ability to maintain performance across multiple platforms will be a key focus going forward, especially amid ongoing macro pressures.

On a separate note, now that the Company has made an acquisition, we are wondering if it will withdraw its shelf filed on November 14, 2024 (when the stock was $17.44) for the stated purpose of making acquisitions.

FitLife Brands is a manufacturer of innovative and proprietary nutritional supplements

Research

Thu, 27 Mar 2025 23:00:47 GMT

FitLife Brands, Inc. (Nasdaq: FTLF) ($13.92, $128.1 million market cap) announced Q4 and full year 2024 results, should be noted that the companyprovided preliminary financials for fourth quarter and full year 2024 on March 13, 2025.

Q4 sales of $15.0 million vs $13.3 million in the prior year
Q4 EPS of $0.21 vs EPS $0.15 in the prior year
Full year sales of $64.5 million vs $52.7 million in the prior year
Full year EPS of $0.91 vs 0.54 in the prior year

“Overall, I am pleased with the Company’s progress in 2024. During the fourth quarter, the Company’s revenue, gross profit, gross margin, contribution, and contribution as a percent of revenue all increased compared to the same period in 2023.

“Over the last several weeks, there has been significant turmoil in the markets, at least partially driven by recessionary concerns and uncertainty related to tariffs. With regard to tariffs, a number of ingredients used in nutritional supplements come predominantly from China. On February 4, 2025, the Trump administration implemented a 10% tariff on most goods coming from China, followed by an additional 10% tariff effective March 4, 2025. Unless withdrawn, these tariffs will increase the Company’s cost of goods sold in future periods. In an effort to mitigate the potential impact of the tariffs, the Company has been opportunistically acquiring certain raw materials at pre-tariff prices to use in future production. One potential benefit of the current economic uncertainty could be increased M&A opportunities for the Company, potentially at lower valuations.

First Quarter and full year 2025 Outlook:

For the first quarter of 2025, both MusclePharm and Legacy FitLife are anticipated to achieve strong double-digit year-over-year online revenue growth. However, online revenue for MRC is expected to decline approximately 10-13%, driven primarily by a diminished seasonal sales lift for the first quarter of 2025 compared to the first quarter of 2024.
On a consolidated basis, the Company currently anticipates a revenue decline of approximately 4-6% for the first quarter of 2025, driven almost entirely by (1) the first quarter of 2024 benefitting from one additional day because of leap year and (2) the challenging year-over-year comparison for MRC.
Despite the anticipated revenue decline, the Company expects adjusted EBITDA for the first quarter of 2025 to be approximately flat compared to the first quarter of 2024. For the full year ended December 31, 2025, the Company expects to deliver organic revenue and EBITDA growth.

FitLife Brands is a manufacturer of innovative and proprietary nutritional supplements.

–

Research

Thu, 13 Mar 2025 15:16:54 GMT

FitLife Brands, Inc. (Nasdaq: FTLF) ($34.88, $3 million market cap) provided updated preliminary financials for fourth quarter and full year 2024:

Net revenue for the full year 2024 is anticipated to be between $64-65 million, an increase of 21-23% compared to 2023. (implies $15.1 Q4 vs $13.3 million)
Adjusted EBITDA for the full year 2024 is anticipated to be between $14.0-14.2 million, an increase of 38-40% compared to 2023.
Net income for the full year 2024 is anticipated to be between $8.9-9.1 million, an increase of 68-72% compared to 2023. (implies $2.1 million for Q4 vs $1.5 million in prior year)
Implies Q4 EPS of $0.22 vs $0.16

FitLife Brands is a manufacturer of innovative and proprietary nutritional supplements.

Research

Thu, 14 Nov 2024 05:00:00 GMT

FitLife Brands, Inc. (Nasdaq: FTLF) ($34.88, $3 million market cap) reported its financial results for the third quarter of 2024:

Q3 sales of $16.0 million vs $14.0 million in the prior year
Q3 EPS of $0.43 vs $0.35 in the prior year

“I am pleased with the Company’s continued strong performance. At MRC, the Dr. Tobias brand—which represents just over 90% of the MRC business—continued to grow despite significant year-over-year reductions in advertising and marketing spend. And although revenue for MRC’s skin care brands has declined significantly due to our decision to exit unprofitable markets and raise prices in others, the brands are substantially more profitable. The MRC brands’ collective contribution of approximately $9.4 million over the last twelve months compares very favorably to the $17.1 million acquisition price the Company paid for MRC.

“For the past couple of years following the COVID pandemic, we have experienced declining sales of our products through brick-and-mortar retailers, primarily due to store closures and declining foot traffic. For the first eight months of 2024, the year-over-year percentage declines in retail sales of FitLife products were in the low double digits. We are encouraged that the rate of decline has improved sequentially in each month over the past four months, with year-over-year declines now in the single digits. Also, as a reminder, the profit impact of wholesale declines for our Legacy FitLife brands are largely offset by the continued growth in high-margin online sales of those products.

With regard to MusclePharm, we are encouraged by the recent wins we have had for the MusclePharm Combat Sport bars and the new MusclePharm Pro Series, and we remain engaged with a number of other prospective customers as we seek to continue to grow the brand.

...The Company continues to evaluate potential M&A opportunities with a specific focus on accretive, non-dilutive transactions.”

FitLife Brands is a manufacturer of innovative and proprietary nutritional supplements for health conscious consumers

Research

Wed, 14 Aug 2024 15:54:00 GMT

FitLife Brands, Inc. (Nasdaq: FTLF) ($32.00, $147.1 million market cap) reported its financial results for the second quarter of 2024:

Q2 sales of $16.9 million vs $14.7 million in the prior year
Q2 EPS of $0.53 vs $0.40 in the prior year

“Overall, I am pleased with the strong performance of our brands, which would not be possible without the continued dedication of each FitLife team member. The Company’s balance sheet is strong, with net debt now representing approximately only 0.9x adjusted EBITDA. Although no transaction is imminent, the Company is currently electing to build cash as it continues to evaluate M&A opportunities. As of August 13, 2024, the Company’s cash balance was $4.4 million.”

FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally.

Research

Tue, 14 May 2024 18:27:48 GMT

FitLife Brands, Inc. (Nasdaq: FTLF) ($30.47, $140.1 million market cap) reported its financial results for the first quarter of 2024:

Q1 sales of $16.5 million vs $5.4 million in the prior year
Q1 EPS of $0.43 vs $0.34 in the prior year
Reduced long term debt by $3.6 million. Company continues to plan to pay down debt which should benefit earnings per share.
It is worth noting that while the company increased revenue by 3x, operating expenses only increased by 5%, showing the operating leverage of the business model.

“The Company is off to a solid start in 2024 and there are many bright spots in our business. At MRC, I am encouraged that the Dr. Tobias brand—which represents approximately 90% of the MRC business—returned to growth during the quarter despite advertising spend that was 39% lower than in the first quarter of 2023. And although the skin care brands continue to struggle on the top line, they are more profitable now than they were at the time of the acquisition. In total, MRC is significantly more profitable than when we made the acquisition.

“Our legacy FitLife brands continue to face headwinds in the wholesale channel due to declining foot traffic at our brick-and-mortar retail partners. Although the declines were partially offset by growth in the legacy FitLife online business, the online growth rate we experienced during the first quarter was lower than anticipated. We are encouraged, though, that the growth rate for legacy FitLife online sales was much stronger during April with a 13% year-over-year increase.

“In addition, I am excited about a number of new products that we will be introducing this year across several of our brands. Of note, we recently re-launched the MusclePharm Combat Sport protein bar in April 2024. We believe the MusclePharm brand is our most significant organic growth opportunity. Both online and wholesale revenue for MusclePharm ramped up throughout the quarter, and we hope to continue the momentum. Overall, our first quarter results demonstrate that we are continuing to execute our goal of profitably growing revenue and paying down debt.”

FTLF is a manufacturer and marketer nutritional supplements for health conscious consumers in the United States and internationally

Research

Wed, 08 May 2024 14:41:26 GMT

FitLife Brands, Inc. (Nasdaq: FTLF) ($28.99, $133.3 million market cap) announced some preliminary data for its upcoming Q1 2024 and its participation in the Sidoti Virtual Investor Conference on May 9, 2024.

Net revenue for the first quarter 2024 is anticipated to be between $16-17 million, an increase of 49-58% compared to the first quarter 2023.
Adjusted EBITDA for the first quarter 2024 is anticipated to be between $3.5-3.7 million, an increase of 56-65% compared to the first quarter 2023.

Based on the EBITDA guidance, our calculations for possible EPS for the quarter is roughly $0.57, which would mean EPS grew strongly over Q1 2023 EPS of $0.11 and sequentially from its Q4 EPS outing of $0.32.

At a P/E of 25, the Q1 run-rate EPS would imply a price target of $57. This does not even include the full impact of the company’s acquisition of MusclePharm.

Research

Mon, 01 Apr 2024 16:51:33 GMT

FitLife Brands, Inc. (Nasdaq: FTLF) ($23.81, $109.2 million market cap) reported its financial results for the fourth quarter of 2023:

Q4 sales of $13.3 million vs $5.4 million in the prior year
Q4 EPS of $0.32 vs $0.10 in the prior year
Full year sales of $52.7 million vs $28.8 million in the prior year
Non-GAAP EPS of $1.51 vs EPS of $0.89 in the prior year

Updates on acquisition integrations:

MRC Integration and Operational Improvements

“The Company continues to drive improved profitability at MRC. As previously reported, the Company reduced year-over-year advertising expense during the second quarter of 2023 by approximately 20% with no material impact on revenue. The Company reduced year-over-year advertising expense by approximately 30% during the third quarter of 2023, resulting in approximately 8% lower revenue but improved profitability. During the fourth quarter of 2023, the Company reduced year-over-year advertising expense by approximately 50%, resulting in approximately 12% lower revenue but significantly improved profitability. “

MusclePharm

“MusclePharm’s contribution to the Company’s performance during fiscal 2023 was immaterial due to (1) the deal closing during the fourth quarter, (2) the need to procure inventory as only $0.2 million of inventory was acquired in the asset purchase, and (3) the need to negotiate new procurement agreements with MusclePharm’s existing customers. Preliminary information about MusclePharm’s contribution to the Company’s performance during the first quarter of 2024 is provided below.”

Preliminary Comments on First Quarter of 2024

“Total Company revenue for the first two months of 2024 was approximately $11 million, of which MRC contributed $4.9 million, legacy FitLife contributed $4.7 million, and MusclePharm contributed $1.4 million. Total Company revenue for the same period in 2023 was $5.2 million.”

Comments from management:

“I am proud of what we accomplished as a company in 2023 and am excited about the future opportunities for our brands. The Company is in the process of launching several new Dr. Tobias and MusclePharm products. Of note, during the second quarter, the Company will be re-launching the MusclePharm Combat Sport protein bar, a product that at its peak sold more than 25 million bars annually. We expect to grow the Company’s revenue and profitability during 2024 while simultaneously reducing our indebtedness. And although our primary focus is the continued integration and growth of our recently acquired brands, we continue to evaluate additional acquisition opportunities.”

An important takeaway from the Fitlife story is that the CEO seems to be obsessed with monitoring marketing-related KPIs to try to extract the most amount of operating leverage from these activities.

He obviously cares more about earnings per share growth than he does about just growing revenue for the sake of getting bigger. And we think he’s just getting started on this goal. EPS should also benefit from the company’s aggressive debt reduction initiatives.

We are extremely excited to see how much profit he can extract from the relaunch of the highly respected MusclePharm products that it recently acquired out ofMusclePharm’z Chapter 11 bankruptcy.

Shares may receive a weak response from investors due to the company’s current debt balance (screens will not take into account debt reduction from December) and the sequentially down quarter from Q3. Ultimately, we believe shares have a shot at trading at P/E of 25 on trailing EPS, equating to a price target of $37.50.

Research

Mon, 13 Nov 2023 05:00:00 GMT

FitLife Brands, Inc. (Nasdaq: FTLF) ($22.0, $109 million market cap),a provider of innovative and proprietary nutritional supplements and wellness products, has released its financial results for the third quarter of 2023. Here is a summary of the key points along with management commentary:

Financial Highlights:

Sales and Earnings Highlights:

Total Revenue: Increased by 67% to $13.9 million, primarily due to an increase in revenue from its recently acquired business, Mimi’s Rock Corp.
Net Income: Grew by 39% to $1.7 million.
Earnings per Share: Basic EPS up by 41% to $0.38
Diluted EPS up by 46% to $0.35.

Other Financial Highlights:

Adjusted EBITDA: Rose by 36% to $2.5 million.
Online Revenue: Constituted 68% of total revenue, a significant increase from the previous year.
Gross Margin: Improved to 41.0% from 39.0%??.

Operational Highlights:

MRC Integration: Achieved cost reductions and improved profitability at Mimi’s Rock Corp (recent acquisition), with significant cuts in advertising expenses, but still leading to increased profitability.
Legacy FitLife: Encountered a 19% decline in revenue, with a strategy to explore new international opportunities and improve online performance??.
MusclePharm Acquisition: Closed the acquisition and initiated the re-launch of successful products, with expectations for online revenue to exceed $5 million in 2024??.

Management Commentary:

Dayton Judd, FitLife’s Chairman and CEO, commented, “Although the third and fourth quarters of each year are traditionally the slowest for the Company, I am pleased with our overall performance. While recent legacy FitLife performance has not met expectations, the weakness has been largely offset by strong financial performance at MRC. Going forward, I am optimistic that legacy FitLife performance will improve, and I am excited about the continued improvements at MRC as well as the potential of the MusclePharm brand to create additional stockholder value.”

Research

Thu, 28 Sep 2023 18:27:50 GMT

Fitlife Brands Inc (OTC:FTLF) ($17.29; $76.8M market cap), a manufacturer and marketer nutritional supplements for health conscious consumers in the United States and internationally, filed an 8K showing it has acquired all the assets of Muscle Pharm Corp (OTC:MSLPQ) in Bankruptcy Court.

FTLF was one of the recent additions to our Buy on Pullback model portfolio we disclosed on September 24, 2023, following that up with a tweet the next day:

The assets to be purchased by the Company consist primarily of intellectual property rights, together with all inventory and supplies, certain contracts. The final purchase price is $18.5 million.

In acquiring the MSLPQ assets, it appears that FTLF will enter the energy drink business by acquiring the FitMiss Energy drink brand from MSLPQ.

How do we know this? If you recall, in 2021, MSLPQ was a turnaround stock that we included in our Model Portfolios for a period of time. Part of our turnaround thesis was the company was entering into the energy drink market, targeting women. At one point the stock increased about 530%.

Unfortunately, after some early progress in implementing a turnaround plan, management was not able to quickly address the impact of the sudden arrival of Inflation and increase in raw material costs at the end of 2022 and its negative impact on gross margins. Due to a weak balance sheet, the company entered into chapter 11 bankruptcy proceedings.

So, we never got to see the company grow its energy drink business. Now, we are very excited to see if FTFL will retain and aggressively market that product line.

What’s nice here is that FTLF could give us a second avenue to play in the energy drink market focused on women. Recall that on August 10, 2023, we added Equator Beverage Co (OOTC:MOJO) to our run to one model portfolio based on the success it has had on growing its line of coconut beverages and its just launched energy drink line focused on the female market.

Research

Mon, 14 Aug 2023 18:28:38 GMT

Fitlife Brands Inc (OTC:FTLF) ($17.97; $79.8M market cap), a manufacturer and marketer nutritional supplements for health conscious consumers in the United States and internationally, announced Q2 2023 results:

Sales of $14.8 million vs $7.8 million in the prior year
Non-GAAP EPS of $0.46 vs EPS of $0.33 in the prior year

“I am pleased with the Company’s performance. In particular, the integration of MRC has been encouraging and we are quickly achieving the anticipated benefits of the acquisition. With regard to the Legacy FitLife business, although wholesale traffic is down, we remain encouraged by the continued growth of our online business. And given the success of our acquisition strategy thus far, we continue to pursue other possible transactions that we believe will be materially accretive to our shareholders.”

Research

Tue, 16 May 2023 14:47:01 GMT

Fitlife Brands Inc (OTC:FTLF) ($17.00; $76.4M market cap), a manufacturer and marketer nutritional supplements for health conscious consumers in the United States and internationally, announced Q1 2023 results:

Sales of $10.7 million vs $7.2 million in the prior year
Non-GAAP EPS of $0.31 vs EPS of $0.26 in the prior year

“I am excited about the future potential for the FitLife and MRC businesses. The combined business performed well during the first quarter, and we are making great progress on a number of initiatives to drive improvement in revenue and gross margins as well as reductions in SG&A and the effective tax rate. Presently, although wholesale traffic is somewhat challenged, we continue to see strong growth in our online business.”

Research

Mon, 27 Mar 2023 13:46:39 GMT

Fitlife Brands Inc (OTC:FTLF) ($17.02; $77.3M market cap), a manufacturer and marketer nutritional supplements for health conscious consumers in the United States and internationally, announced Q4 2022 results:

Sales of $5.4 million vs $6.9 million in the prior year
EPS of $0.10 vs EPS of $0.26 in the prior year
During the fourth quarter of 2022, the Company repurchased 48,596 common shares in multiple private transactions at an average price of $15.86 per share, for total consideration of approximately $0.8 million. All of the repurchased shares were canceled.

“Prior to COVID, procurement lead times rarely exceeded eight weeks, which allowed the Company to operate more efficiently with less inventory. However, at the peak of the supply chain disruption, lead times frequently exceeded six months. Presently, for most products, the Company is experiencing lead times of approximately 12-16 weeks, and procurement costs for almost all of our products are declining. The Company, which accounts for inventory on a FIFO basis, anticipates continued near-term margin pressure for FitLife products as it finishes selling through higher-cost inventory, with margins anticipated to expand thereafter. In addition, as lead times shorten, the Company anticipates that during fiscal 2023 it will be able to reduce the amount of inventory that it carries.”

Preliminary Q1 2023 guidance:

“The Company has experienced strong performance thus far during the first quarter of 2023. For the legacy FitLife business, online revenue has continued its strong growth, and wholesale revenue has increased as well. For the first quarter of 2023, the Company currently expects total revenue growth for the legacy FitLife business in the range of 8-12%. Management is also pleased with the initial performance of MRC. Including the 32 days of revenue contribution from MRC during the quarter, the Company currently anticipates total revenue for the first quarter of 2023 to be between $10.4 and $11.0 million.”

Research

Wed, 01 Mar 2023 17:44:40 GMT

Fitlife Brands Inc (OTC:FTLF) ($19.00; $86.3M market cap), manufactures and markets nutritional supplements for health conscious consumers in the United States and internationally announced it has completed the acquisition of Mimi’s Rock Corp.

“Transformative acquisition will double the size of FitLife with minimal leverage and no dilution to shareholders”

“We are excited to welcome Mimi’s Rock to the FitLife family. We look forward to working closely with the talented team at Mimi’s Rock to help drive further growth and profitability for their brands.”

On December 5, 2022 we highlighted that the company had entered into a definitive agreement with Mimi Rock.

Research

Mon, 05 Dec 2022 15:13:19 GMT

Fitlife Brands Inc (OTC:FTLF) ($14.60; $66.3M market cap), manufactures and markets nutritional supplements for health conscious consumers in the United States and internationally announced it has entered definitive agreement to acquire Mimi’s Rock Corp, an online dietary supplement and wellness company which markets and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.

In our September 11, 2022 weekly wrap-up, we mentioned that FTLF may be looking at a substantial acquisition based on the shareholder letter from the company. In our September 11, 2022 Weekly Wrap-up, “Shareholder Letter Has Stalwart Fitlife Brands Back On Our Radar”, we wrote:

“Now, they may be looking at more substantial acquisitions that could materially increase the size of the company with no dilution. The stock has recovered nicely from a pull back that might have been due to an ongoing financial restatement process.”

At first glance, the transaction seems to be very transformative.

Highlights of the transaction from the press release include:

The transaction, which has been unanimously approved by the boards of directors of both companies, is expected to approximately double the size of the Company to more than $60 million annual revenue
Annual adjusted EBITDA of the combined businesses is anticipated to exceed $12 million
The all-cash transaction, with no shares being issued by FitLife, is expected to be highly accretive to existing shareholders once all transaction-related costs have been expensed
The total transaction value is approximately CDN $27.2 million (approximately $20.3 million US dollars at current exchange rates)
After adjustment for transaction expenses and working capital, the remaining consideration paid by FitLife will retire all of MRC’s outstanding indebtedness and fund payment to Mimi’s Rock shareholders of CDN $0.17 per share
The Company expects to incur $1.2-1.5 million in transaction expenses, and post-closing the Company anticipates investing approximately $2.0 million to enhance MRC’s working capital
Mimi’s Rock shareholders owning approximately 47% of the outstanding shares have entered into voting agreements in support of the transaction
The purchase will be funded using a combination of cash on hand and a committed term loan to be provided by the Company’s bank, First Citizens Bank, with a rate of SOFR+275
Post-closing, total FitLife leverage will be minimal, with net debt/pro forma EBITDA expected to be comfortably below 1.0x, and the Company anticipates being debt-free within approximately one year of closing the transaction
Revenue concentration with GNC, the Company’s largest customer, is expected to decline from 65-70% currently to 30-35% for the combined businesses
Online revenue as a percent of total revenue is expected to increase from approximately 26% currently to 60-65% for the combined businesses

Research

Fri, 11 Nov 2022 15:24:07 GMT

Fitlife Brands Inc (OTC:FTLF) ($16.00; $72.8M market cap), manufactures and markets nutritional supplements for health conscious consumers in the United States and internationally announced Q3 2022 results:

Sales of $8.3 million vs $6.7 million in the prior year
EPS of $0.24 vs EPS of $0.23 in the prior year

“Management expects the Company’s wholesale revenue trends to remain lumpy based on the ordering patterns of our customers. As a result, we encourage investors to evaluate revenue trends for the wholesale channel over periods of two or more quarters. Growth in consumer purchases of the Company’s products in the wholesale channel, which tends to be a more stable indicator of demand, was positive during the third quarter, and remains positive thus far in the fourth quarter.

Despite a somewhat challenging operating environment, I am encouraged by the continued growth in our wholesale and online businesses. We continue to actively pursue opportunities to deploy our strong and growing cash balance into accretive acquisitions.”

Research

Sun, 25 Sep 2022 04:00:00 GMT

Fitlife Brands Inc (OTC:FTLF) is a manufacturer and marketer of nutritional supplements for health conscious consumers in the United States and internationally. The company issued an 8K with its restated financials for the periods of 2019 through June 2021. It is nice to see the company is making good progress to become current with its financials and commitment not to go dark.

Summary below:

2019 - Previously reported sales of $19.5 mil restated to $19.1 mil with EPS of $2.41 restated to $2.33
2020 - Previously reported sales of $19.5 mil restated to $19.1 mil with EPS of $2.41 restated to $2.33
First half 2021 - Previously reported sales of $14.2 mil restated to $14.0 mil with EPS of $2.69 restated to $2.57

Management's comments on becoming current:

“Immediately preceding the filing of the 2020 Form 10-K/A and the 2021 Form 10-K, management currently intends to withdraw its Form 15 filed with the Securities and Exchange Commission, and thereafter file its quarterly reports on Form 10-Q for the first two quarters of 2022.”

Research

Mon, 12 Sep 2022 13:07:52 GMT

RFT Update

Fitlife Brands Inc (OTC:FTLF) is a manufacturer and marketer of nutritional supplements for health conscious consumers in the United States and internationally. We’re going to start watching FTLF a little closer due to the contents in a mid-year shareholder letter that the company issued in a July 8k in conjunction with its December 2021 year end results.

You can see our prior coverage on FTLF here. GeoInvesting research contributor, Avram Fisher, published his bullish thesis on July 29, 2016 at a price of $3.45. We subsequently published a ‘Reasons For Tracking (RFT) piece on the company on November 23, 2018 at a price of $1.38 (report prices adjusted for splits - 1:10 on 4/16/2019 and 4:1 on 12/8/2021).

Over the last several years, the current CEO and once activist, Dayton Judd, has done a good job turning around the company,saving it from bankruptcy due to a heavy reliance on GNC. He has:

Cleaned up the balance sheet
Expanded retail distribution
Placed a greater emphasis on building the company's online presence.
Made a small tuck in acquisition where sales have doubled in about 18 months.

Now, they may be looking at more substantial acquisitions that could materially increase the size of the company with no dilution. The stock has pulled back sharply due to an ongoing financial restatement process.

Revenues in 2021 were down due to strong "COVD Bump" related sales in 2020. However, sales in the first half of 2022 (see Q1, Q2) were up nicely, but management commented that the second half of 2022 may be more challenging. Despite some of the short-term uncertainty in the story, we will continue to closely track the company for a resolution in their restatement efforts and for the possibility of a large acquisition.

The company has about $10 million in cash and no long-term debt. Shares are trading at a run-rate P/E of around 15x.

The CEO is committed to becoming a reporting company and actually pursuing a NASDAQ listing. We plan to:

Interview the CEO
Gain an understanding on expansion of retail distribution efforts
Glean more color on what type of acquisition the company would find desirable. For example, would management be looking to acquire brands or potentially execute an acquisition that could accelerate the growth of its online business?
Address seasonality in quarters.

Shareholder letter quote:

“Obviously, we are being very disciplined in our M&A efforts. We could have acquired many of the companies we have evaluated, but we do not want to consummate a bad or risky transaction. One benefit of being disciplined is that our cash balance and EBITDA continues to grow. This allows us to look at even larger transactions that have the potential to drive much greater impact than a smaller transaction. In its current financial position, the Company could easily execute a $30 million acquisition using cash on hand and a modest, manageable amount of debt. Presently, the Company has no intention to use its equity as a currency in a potential transaction.”

Putting this passage into context, the company's current revenue run rate is approximately $30.0 million.

Research

Wed, 08 Dec 2021 19:03:44 GMT

Fitlife Brands Inc (OTC:FTLF) ($50.00; $56.2M market cap), a manufacturer and marketer of nutritional supplements for health conscious consumers in the United States and internationally, announced the board of directors has authorized a forward stock split of 4 for 1 to begin on December 8, 2021.

You can see our prior coverage on FTLF here.

Research

Tue, 17 Aug 2021 17:01:53 GMT

Fitlife Brands Inc (OTC:FTLF) ($41.75; $45.7M market cap), manufactures and markets nutritional supplements for health conscious consumers in the United States and internationally announced Q2 2021 results:

Sales of $8.1 million vs $2.7 million in the prior year
EPS of $1.26 vs a loss of $0.09 in the prior year

“The second quarter of 2021 was one of the strongest quarters in the Company’s history. We continue to experience robust organic growth in both our wholesale and our online businesses. We have successfully integrated Nutrology into our operations, and we continue to look for opportunities to deploy our strong and growing cash balance into additional accretive acquisitions.”

You can see our prior coverage on FTLF here. The stock is now up 202% since GeoInvesting research contributor, Avram Fisher, published his bullish thesis at a price of $13.80 in July 2016 and up over 600% since we published an RFT on the company in November 2018 at a price of $5.30.

Research

Fri, 14 May 2021 04:00:00 GMT

Fitlife Brands Inc (OTC:FTLF) ($38.0 prior close; $41.1M market cap), manufactures and markets nutritional supplements for health conscious consumers in the United States and internationally announced Q1 2021 results:

Sales of $6.2 million vs $6.2 million in the prior year
EPS of $1.56 vs $1.43 in the prior year

For the first quarter ended March 31, 2021, total revenue was approximately flat at $6.2 million. As previously mentioned, the Company believes that a portion of the wholesale revenue that historically would have been received during the first quarter shifted into the fourth quarter of 2020. For the first quarter of 2021, online sales increased 89.2% to $1.6 million and accounted for approximately 26% of the Company’s total revenue compared to 14% during the first quarter of 2020.

Dayton Judd, the Company’s Chairman and CEO, commented, “I am pleased that we continue to experience organic growth in both our wholesale and our online businesses. And as our online revenue becomes a larger portion of our business, we benefit from higher margins, as evidenced by the 50% gross margins we achieved during the first quarter.”

“Over the past several months, the global supply chain for nutritional supplement ingredients and packaging has become increasingly challenging. Production lead times for many of our products have increased from two months to as much as six months in some cases. In an effort to ensure our products stay in stock, we are placing orders much earlier than usual and carrying larger quantities of inventory. We will continue to adapt our operations as necessary to compete effectively in the current environment.”

Research

Wed, 14 Apr 2021 16:37:28 GMT

Fitlife Brands Inc (OTC:FTLF) ($32.00; $38.2M market cap), a company that manufactures and markets nutritional supplements for health conscious consumers in the United States and internationally, announced the acquisition of Nutrology, which caters to consumers who prioritize all-natural and plant-based nutritional supplements. It is an all cash transaction and expected to be immediately accretive to earnings. Financial details have not yet been disclosed.

Research

Mon, 29 Mar 2021 04:00:00 GMT

Fitlife Brands Inc (OTC:FTLF) ($24.04 prior close; $37.1M market cap), manufactures and markets nutritional supplements for health conscious consumers in the United States and internationally announced Q4 2020 results:

Sales of $5.9 million vs $3.7 million in the prior year
Non-GAAP EPS of $1.17 vs $0.04 in the prior year

“The Company’s performance continues to exceed expectations in both our wholesale and direct-to-consumer channels. As a result, the Company has been able to achieve strong revenue growth and profitability, and our balance sheet continues to strengthen, despite the effects of the COVID-19 pandemic and the bankruptcy of the Company’s largest customer during 2020. The Company continues to search for opportunities to deploy cash for prudent, immediately accretive acquisitions.”

FTLF's financial performance, along with other companies in the nutritional supplement and healthy lifestyle products industry has us excited to see Muscle Pharm Corp (NASDAQ:MSLP) 2020 Q4 financial results which are due out soon. You can read more about why we began covering MSLP here.

Research

Thu, 13 Aug 2020 04:00:00 GMT

Second Quarter 2020 Results

Sales of $2.7 milliion vs $4.6 million in the prior year
Loss of $0.09 vs EPS of $0.43 in the prior year

Revenue trends during the quarter

Retail sales of the Company’s products through GNC franchise locations experienced a year-over-year decline of 50-55% during late March and early April, before beginning a steady recovery. By late May, retail sales of the Company’s products had returned to experiencing low single-digit percentage growth on a year-over-year basis, which growth continued through the end of the quarter. The Company’s wholesale revenue increased sequentially each month throughout the quarter as well.

GNC Bankruptcy

The Company’s largest customer, GNC, filed for Chapter 11 bankruptcy protection on June 23, 2020. At the time of the filing, GNC owed the Company approximately $1.2 million.

Preliminary Report on Third Quarter

Given the rapidly changing retail environment, the Company understands the importance of transparency to its shareholders and other stakeholders. Therefore, as it has done in the past, the Company provides the following information, not subject to any procedures by our Independent Registered Public Accounting Firm, regarding its performance and position as of August 12, 2020.

Revenue for the month of July 2020 was among the strongest of any months in the Company’s history and was roughly equivalent to the total revenue generated by the Company in all of the second quarter ended June 30, 2020.
For the quarter to date, the Company has generated revenue of $3.7 million, an increase of 64% over the same period in the third quarter of 2019. A significant part of this growth relates to a restocking of our products with GNC subsequent to its bankruptcy filing, and the Company anticipates that this pace of revenue growth will not continue through the remainder of this quarter
We continue to see increasing demand for our products from end consumers both in-store and online.
Retail sales of the Company’s products in GNC franchise locations for the quarter to date continue to experience low single-digit percentage growth on a year-over-year basis.

"The second quarter was particularly challenging for the Company, given the effects of the COVID-19 pandemic and the bankruptcy filing of GNC, our largest customer. However, going forward, a restructured GNC will be a better customer for the Company for a number of reasons. While we continue to navigate the effects of both COVID-19 and the GNC bankruptcy, I am very pleased with the performance of our team, our brands, and our Company, and I am optimistic about the Company’s direction and performance going forward.”

Research

Fri, 15 May 2020 19:25:59 GMT

Fitlife Brands Inc (OTC:FTLF) ($9.12; $9.6M market cap), manufactures and markets nutritional supplements for health conscious consumers in the United States and internationally announced Q1 2020 results:

Sales of $6.2 million vs $5.9 in the prior year
EPS of $1.29 vs $0.94 in the prior year

“I am very pleased with the Company’s performance during the first quarter, especially given the disruption that began in mid-March due to the COVID-19 pandemic. That said, given the uncertainty brought on by the current environment, I know our stakeholders are more interested in how the business is performing during the second quarter. Therefore, to be as transparent as possible, the Company provides the following information, not subject to any procedures by our Independent Registered Public Accounting Firm, regarding its performance and position as of May 14, 2020.”

Total accounts receivable outstanding is $1.1 million, of which approximately 66% is due from GNC.
Most of our customers continue to pay us timely in the ordinary course of business. However, several customers owing a combined total of $0.1 million are currently three or more weeks behind in making payments, and roughly 30% of that amount has already been fully reserved and is not included in the total accounts receivable balance reported above.
The Company repaid its line of credit in late April, and the full balance of the $2.5 million facility is available to draw again in the future as needed, subject to any borrowing base limitations.
Total cash on hand is $2.9 million.
The Company continues to pay all of its vendors timely in the ordinary course of business.
Thus far during the second quarter, the Company’s direct-to-consumer online revenue is pacing roughly 100% higher than online revenue during the same time period last year.
Retail sales of the Company’s products through GNC franchise locations experienced a year-over-year decline of 50-55% during late March and early April, but have been improving consistently each week since then, with recent declines in the 10-20% range relative to the same time period last year.
The Company generated no revenue from GNC during April, as the warehouses and the franchisees worked through existing inventory.
Beginning in the first half of May, the Company received orders from and has begun shipping products to GNC. Nevertheless, the Company anticipates that its revenue from GNC will be materially lower during the second quarter of 2020 compared to the same quarter last year.
Due to cost-cutting efforts, the Company anticipates that operating expense for the second quarter of 2020 will be at least 7-10% lower than the first quarter of 2020.

Research

Mon, 30 Mar 2020 14:29:04 GMT

Fitlife Brands Inc (OTC:FTLF) ($8.55; $7.9M market cap), manufactures and markets nutritional supplements for health conscious consumers in the United States and internationally announced Q4 2019 results:

Sales of $3.7 million vs $3.5 million in the prior year
EPS of $0.33 vs a loss of $0.28 in the prior year

“By all accounts, the Company’s performance during 2019 was solid. We have returned to growth in old channels and continued growth in new channels, all while reducing operating expenses and improving the balance sheet. That said, the current economic environment is expected to materially impact the Company’s brick and mortar wholesale customers. In light of the uncertainty and in order to preserve its financial flexibility, the Company elected to draw the full $2.5 million available under its line of credit.”

FTLF remains a small long position.

Research

Mon, 11 Nov 2019 19:09:18 GMT

Fitlife Brands Inc (OTC:FTLF) ($10.11; $10.2M market cap), manufactures and markets nutritional supplements for health conscious consumers in the United States and internationally, announced Q3 2019 results:

Sales of $5.3 million vs $4.6 million in the prior year
EPS of $0.72 vs $0.31 in the prior year

“I continue to be pleased with the Company’s performance. After many quarters of decline, the Company’s wholesale business returned to growth with GNC as well as with other wholesale partners. And we are excited about the launch of our liquid L-Carnitine product in 3,700 Walmart stores throughout the US. In addition, we continue to experience growth in online revenue, and recently launched new online-exclusive products during the fourth quarter.

Mr. Judd continued, “Going forward, we intend to focus on driving continued organic growth. In addition, given our improved performance and strong balance sheet, the Company intends to explore opportunities to grow through prudent acquisitions. And, the Company intends to continue to repurchase shares as long as they remain an attractive investment option.”

Research

Mon, 12 Aug 2019 15:08:12 GMT

Fitlife Brands Inc (OTC:FTLF) ($10.55; $10.7M market cap), manufactures and markets nutritional supplements for health conscious consumers in the United States and internationally, announced Q2 2019 results:

Sales of $4.6 million vs $4.4 million in the prior year
EPS of $0.29 vs $0.16 in the prior year

“I am pleased that the Company’s operations continue to improve. Our improved cost structure and financial flexibility is giving us the freedom to invest in marketing and explore other opportunities to further strengthen and grow our Company.”

Research

Thu, 16 May 2019 15:28:40 GMT

Fitlife Brands Inc (OTC:FTLFD) ($6.85; $7.6M market cap) manufactures and markets nutritional supplements for health conscious consumers in the United States and internationally announced Q1 2019 results:

Sales of $5.9 million vs $4.6 million in the prior year
EPS of $0.94 vs $0.20 in the prior year

Following the Reverse/Forward Split, there are 1,014,740 shares of the Company’s common stock outstanding.

“I am pleased with the Company’s performance during the first quarter of 2019. Our team has improved the performance of almost all of our brands, and our efforts to diversify into online revenue sources are off to a good start. The combination of stronger top-line performance, expanding margins due to online sales, and lower operating costs resulted in a record quarter for the Company.

Our online strategy varies by brand. For our GNC-exclusive brands, our focus is on eliminating unauthorized online resellers in order to protect our GNC franchise partners. For our other brands, we are pricing our products competitively to drive revenue and unit growth. Given this strategy, our top-selling products online include Energize as well as some of our iSatori products. Going forward, we intend to continue executing our strategy. With our improved performance and stronger balance sheet, we also intend to invest more money into marketing in an effort to continue to drive profitable top-line growth for all of our brands.”

You can see our reasons for tracking from November 23, 2018 here.

Research

Tue, 16 Apr 2019 14:51:07 GMT

Fitlife Brands Inc (OOTC:FTLF) ($0.58; $6.4M market cap) manufactures and markets nutritional supplements for health conscious consumers in the United States and internationally. We have covered some insider buying activity over the last several months and offered our reasons for tracking back in November 2018, which can be seen here.

In an 8-K filed yesterday, it seems the Company intends to go dark:

“On April 11, 2019, FitLife Brands, Inc. (the “ Company ”) filed two Certificates of Change with the Secretary or State of the State of Nevada, copies of which are attached hereto as Exhibit 3.1, the first to effect a reverse stock split of both the Company’s issued and outstanding and authorized common stock, par value $0.01 per share (“ Common Stock ”), at a ratio of 1-for-8,000 (the “ Reverse Split ”), and the second to effect a forward stock split of both the Company’s issued and outstanding and authorized Common Stock at a ratio of 800-for-1 (the “ Forward Split ,” and together with the Reverse Split, the “ Reverse/Forward Split ”). The Reverse/Forward Split will become effective on Tuesday, April 16, 2019 on or about 12:01 a.m. PST.”

The company plans to execute a 1 for 8000 reverse split, in essence getting rid of any shareholders who own less than 8000 shares. It intends on then applying an 800 to 1 forward split for remaining shareholders. After both adjustments are made, it will result in a 10 for 1 split, leaving the outstanding share count at around 1.1 million shares.

A summary from Investopedia on why companies may choose to do such a transaction is below:

A reverse/forward stock split is a stock split strategy used by companies to eliminate shareholders that hold fewer than a certain number of shares of that company's stock. A reverse/forward stock split uses a reverse stock split followed by a forward stock split. The reverse split reduces the overall number of shares a shareholder owns, causing some shareholders who hold less than the minimum required by the split to be cashed out. The forward stock split increases the overall number of shares a shareholder owns. A reverse/forward stock split is usually used by companies to cash out shareholders with a less-than-certain amount of shares. This is believed to cut administrative costs by reducing the number of shareholders who require mailed proxies and other documents.

Research

Fri, 29 Mar 2019 14:18:18 GMT

Fitlife Brands Inc (OOTC:FTLF) ($0.53; $6.1M market cap) manufactures and markets nutritional supplements for health conscious consumers in the United States and internationally. In November, we started to pay closer attention to the new CEO’s aggressive share buying, even as the stock hit new highs. The buying continued in February with the CEO adding 235,000 shares at open market prices. The company reported full year 2018 results on March 22, 2019.

Sales of $17.1 million vs $17.8 million in the prior year
EPS of $0.04 vs a loss of $0.32 in the prior year
Q4 sales of $3.6 million vs $3.2 million in the prior year
Q4 loss of $0.03 vs a loss of $0.18 in the prior year

“2018 was a year of transition for FitLife Brands. While revenue declined for the full year, we returned the company to year-over-year revenue growth in the third and fourth quarters of the year. We also right-sized the company’s cost structure, eliminating over $2 million, or 25%, of our annual operating expense. The combination of returning to revenue growth and a reduced cost structure should drive improved performance for the business going forward. We also significantly improved the company’s balance sheet, transitioning from being in default on $2.4 million of debt at the end of 2017 to a much more manageable debt load of $0.5 million at the end of 2018.“

Mr. Judd added, “We continue to focus on selling more of our products online. We expect to launch a new, integrated website within the next couple of weeks, offering the full product lines for each of our eight brands to the end consumer in one location. In addition, we continue to experience growth in sales of our products on Amazon and on eBay. Beginning with the first quarter of 2019, we intend to provide a breakdown of our online revenue compared to our wholesale revenue.”

You can see our full reasons for tracking from November 23, 2018 here.

Research

Tue, 22 Jan 2019 15:41:31 GMT

Fitlife Brands Inc (OOTC:FTLF) ($0.53; $6.1M market cap) manufactures and markets nutritional supplements for health conscious consumers in the United States and internationally. In November, we started to pay closer attention to the new CEO’s aggressive share buying, even as the stock hit new highs. Shares temporarily dipped back to $0.27 in late December 2018, before bouncing back and regaining a high of $0.55 on January 18, 2019. We continue to monitor insider transactions.

You can see our full reasons for tracking from November 23, 2018 here.

Research

Tue, 08 Jan 2019 16:07:39 GMT

Fitlife Brands Inc (OOTC:FTLF) ($0.53; $5.8M market cap) manufactures and markets nutritional supplements for health conscious consumers in the United States and internationally. In a form 4 filed yesterday after the close, CEO Dayton Judd added roughly 1.1 million shares in two private transactions.

In November we started to pay closer attention to the new CEO’s aggressive share buying, even as the stock hit new highs. You can see our full reasons for tracking from November 23, 2018 here.

Reasons For Tracking

Fri, 23 Nov 2018 15:58:16 GMT

In our October 24th, 2018 email, we mentioned that we were ramping up our OTC pipeline and that we wanted to delve into FTLF a bit more to see if new the CEO, who joined earlier this year, has put the company on a path to consistent growth - something that has not occurred over the last several years.

We were are intrigued that the new CEO has been aggressively buying shares, even as the stock hits new highs. We are not huge fans of FTLF but a few members asked us to take a closer look at the company. You can see a comprehensivereport by a GeoInvesting member Avram Fisher, who was slightly bullish on the company at one point in 2016, but did a good job highlighting the uncertainties surrounding its comeback story. The stock did experience a brief run-up and Avi eventually turned bearish on FLTF. You can see his latest update here.

Fitlife Brands Inc (OOTC:FTLF) ($0.53; $5.8M market cap) manufactures and markets nutritional supplements for health conscious consumers in the United States and internationally. FTLF offers various nutritional supplements for health conscious consumers marketed under the brand names NDS Nutrition Products™, PMD®, SirenLabs®, CoreActive®, Metis Nutrition™, iSatori™, Energize and BioGenetic Laboratories.

Please see our full reasons for tracking here.

Research

Fri, 29 Jul 2016 14:03:40 GMT

GeoInvesting’s latest contributor article is on $FTLF “FTLF: A Turnaround Trade with 75% Upside Potential”, by Avram Fisher at Long Cast Advisors.

FTLF sells sports nutritional supplements, primarily to GNC franchise stores and it ...

operates to be profitable and cash flow positive
experienced temporary not terminal issues last year that investors misunderstood
those issues anniversaried, so comps are low
combined with the acquisition of a distressed competitor should result in 60% y/y sales growth for 2016 and EPS in the $0.20-$0.25 range for the year.
Longer term there’s an add’l boost from GNC's "refranchising strategy" but also a lot of uncertainty around this core customer, which has some “warts”.

... if these attributes hold steady there is an opportunity for investors to earn a potentially high return in less than a year's time.

See the entire article here.

Comments & Business Outlook

Thu, 08 Oct 2009 04:00:00 GMT

John S. Wilson, CEO of Bond Laboratories Inc., added, “NDS is on pace in 2009 to significantly exceed prior year financial performance and anticipates strong revenue and profitability growth through 2010 driven by continued efforts to reduce costs, expand distribution capabilities, and develop market leading products.

Source: Business Wire (October 7, 2009)